Comera Life Sciences Holdings, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Comera Life Sciences Holdings, Inc. reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$1.51 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2023-11-09
- Comera Life Sciences Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2023-09-30 was $266.36K.
- Comera Life Sciences Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2023-06-30 was -$405.56K, a 157.86% decline year-over-year.
- Comera Life Sciences Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2023-03-31 was $137.69K.
- Comera Life Sciences Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2022-12-31 was $408.75K, a 8.45% increase year-over-year.
- Comera Life Sciences Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $789.15K, a 97.39% increase from fiscal 2021.
- Comera Life Sciences Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2021 was $399.80K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2023-09-30 | $266.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$139.21K derived: sum of 2 quarters · filed 2023-11-09 | -$1.51K 10-Q · filed 2023-11-09 | $407.24K derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | -$405.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$267.87K 10-Q · filed 2023-08-10 | $140.89K derived: sum of 3 quarters · filed 2023-08-10 | $121.12K derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | $137.69K 10-Q · filed 2023-05-12 | $546.45K derived: sum of 2 quarters · filed 2023-05-12 | $526.68K derived: sum of 3 quarters · filed 2023-11-09 | $1.23M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | $408.75K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $388.99K derived: sum of 2 quarters · filed 2023-11-09 | $1.09M derived: sum of 3 quarters · filed 2023-11-09 | $789.15K 10-K · filed 2023-03-17 |
| 2022-09-30 | -$19.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $681.17K derived: sum of 2 quarters · filed 2023-11-09 | $380.40K 10-Q · filed 2023-11-09 | $757.30K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $700.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $400.17K 10-Q · filed 2023-08-10 | $777.06K derived: sum of 3 quarters · filed 2023-08-10 | $651.92K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$300.77K 10-Q · filed 2023-05-12 | $76.13K derived: sum of 2 quarters · filed 2023-05-12 | -$49.01K derived: sum of 3 quarters · filed 2023-05-12 | |
| 2021-12-31 | $376.90K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $251.76K derived: sum of 2 quarters · filed 2023-03-17 | $399.80K 10-K · filed 2023-03-17 | |
| 2021-09-30 | -$125.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $22.91K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $148.04K 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $82.22K 8-K · filed 2022-09-06 |